INS and obesity due to melanocortin 4 receptor deficiency: Therefore, it is not surprising that especially metabolically unhealthy obesity (MUO), a subset of obesity characterized by cardiometabolic complications, higher liver fat content, insulin resistance, inflammation and adipose tissue dysfunction, has been recognized as a major risk factor for COVID-19 severity and mortality [3–7].